secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2023-02-02T23:59:59+00:00
Accession:  0001022079-23-000006
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q4 revenue down 15% to $2.33B; base business up 6.3%; raises dividend 7.6%
--------------------------------------------------------------------------------

- Q4 reported net revenues $2.33B (-15% YoY); base business revs $2.15B (+6.3%); COVID revs $184M (-74.6%).
- Q4 reported diluted EPS $0.87 (down 72.1%); adjusted diluted EPS $1.98 (down 40.5%).
- Full year 2022 net revenues $9.88B (-8.4%); base business revs $8.43B (+5.1%); COVID revs $1.45B (-47.5%).
- FY2023 guidance: net revs $8.83-9.03B; base business up 2.6-3.8%; adjusted EPS $8.40-$9.00.
- Board increased quarterly dividend 7.6% to $0.71 (payable Apr 24) and authorized additional $1B share repurchase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207923000006/0001022079-23-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207923000006/dgx-20230202.htm
  HTML page:      https://secwatch.observer/filing/0001022079-23-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer